GENPREX INC
GNPX · NASDAQ
Updated at 2026-10-14 09:34:49
- Today's High
- $2.69
- Today’s Low
- $2.51
%22%2F%3E%0A%3Cpath%20id%3D%22%26%23230%3B%26%23150%3B%26%23135%3B%26%23230%3B%26%23161%3B%26%23163%3B%26%23230%3B%26%23154%3B%26%23151%3B%26%23232%3B%26%23167%3B%26%23146%3B%22%20d%3D%22M48.3363%2013.4132H60.2082L46.795%205.72205e-06V11.8719C46.795%2012.7231%2047.4851%2013.4132%2048.3363%2013.4132Z%22%20fill%3D%22var(--fill-0%2C%20%23474741)%22%2F%3E%0A%3Cpath%20id%3D%22%26%23230%3B%26%23148%3B%26%23190%3B%26%23229%3B%26%23164%3B%26%23167%3B%26%23233%3B%26%23149%3B%26%23156%3B%22%20fill-rule%3D%22evenodd%22%20clip-rule%3D%22evenodd%22%20d%3D%22M11.3812%2020.3725C16.7977%2014.9559%2025.5803%2014.9559%2030.9969%2020.3725C36.413%2025.789%2036.4131%2034.5707%2030.9969%2039.9872C26.0109%2044.973%2018.1729%2045.3699%2012.7335%2041.1769L2.54298%2051.3684L0%2048.8254L10.1915%2038.6329C5.99993%2033.1937%206.39609%2025.3579%2011.3812%2020.3725ZM28.4539%2022.9155C24.4418%2018.9033%2017.9363%2018.9033%2013.9241%2022.9155C9.91245%2026.9275%209.91241%2033.4322%2013.9241%2037.4442C17.9362%2041.4562%2024.4418%2041.4562%2028.4539%2037.4442C32.4656%2033.4322%2032.4656%2026.9275%2028.4539%2022.9155Z%22%20fill%3D%22var(--fill-0%2C%20%235D5D56)%22%2F%3E%0A%3C%2Fg%3E%0A%20%20%3C%2Fsvg%3E%0A%3C%2Fsvg%3E%0A)
Candlestick trends are for reference. Refer to the trading page for actual data.
Key Statistics
- Previous Open
- $2.88
- Previous Close
- $2.69
- Volume
- 283.45K
- Market Cap
- $2.2M
- P/E Ratio
- --
- EPS
- $-173.00
Previous Day Range
52-Week Range
Company Overview
- Sector
- HEALTHCARE
- Industry
- Biotechnology
- Sub-industry
- BIOTECHNOLOGY
- Headquarters
- 3300 BEE CAVE ROAD, AUSTIN, TX, UNITED STATES, 78746
- Country
- US
- Listing Date
- 2018-03-29
- Fiscal Year End
- December
- Shares Outstanding
- 500K
- CIK
- 0001595248
- Website
- www.genprex.com
Genprex, Inc., a clinical-stage gene therapy company, focuses on developing therapies for patients with cancer and diabetes. The company is headquartered in Austin, Texas.
Financial Metrics
Revenue
2026-06-30
$0
2026-03-31
$0
2025-12-31
$0
2025-09-30
$0
Operating Expenses
2026-06-30
$4.48M
2026-03-31
$4.49M
2025-12-31
$3.51M
2025-09-30
$3.34M
Net Income
2026-06-30
-$4.44M
2026-03-31
-$4.46M
2025-12-31
-$3.79M
2025-09-30
-$3.79M
Net Profit Margin
2026-06-30
--
2026-03-31
--
2025-12-31
--
2025-09-30
--
Earnings Per Share
2026-06-30
$-9.40
2026-03-31
$-14.11
2025-12-31
$-25.33
2025-09-30
$-5.00
Earnings Before Interest, Taxes, Depreciation, and Amortization
2026-06-30
-$4.44M
2026-03-31
-$4.46M
2025-12-31
-$3.5M
2025-09-30
-$3.34M
Effective Tax Rate
2026-06-30
--
2026-03-31
--
2025-12-31
--
2025-09-30
--
| Item | 2026-06-30 | 2026-03-31 | 2025-12-31 | 2025-09-30 |
|---|---|---|---|---|
| Revenue | $0 | $0 | $0 | $0 |
| Operating Expenses | $4.48M | $4.49M | $3.51M | $3.34M |
| Net Income | -$4.44M | -$4.46M | -$3.79M | -$3.79M |
| Net Profit Margin | -- | -- | -- | -- |
| Earnings Per Share | $-9.40 | $-14.11 | $-25.33 | $-5.00 |
| Earnings Before Interest, Taxes, Depreciation, and Amortization | -$4.44M | -$4.46M | -$3.5M | -$3.34M |
| Effective Tax Rate | -- | -- | -- | -- |
FAQs
Risk Warning
Stock prices can be highly volatile and may rise or fall sharply in a short period. Digital asset and derivative products involve additional risks such as leverage and liquidity. Content on this page is for reference only and does not constitute investment advice. Product availability and access may vary by region and applicable regulations.